Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related CELG
3 Biotech Stocks Bucking Short Interest Trends
Is It Closing Time At The Biotech Bar?
A Buyback Or Biotech Bubble? (Seeking Alpha)
Related FB
Exclusive: Moneyball Economist On Smoking Pot 'Keurig Green Mountain' Style
A Glimpse Into Facebook's Future
Facebook F8 Wrap-Up: Bullish On Messenger And Oculus (Seeking Alpha)

Analysts at Deutsche Bank upgraded Celgene (NASDAQ: CELG) from “hold” to “buy.” The target price has been raised from $105.00 to $143.00. Celgene closed at $115.95 yesterday.

Analysts at Argus Research upgraded Facebook (NASDAQ: FB) from “hold” to “buy.” The target price for Facebook is set to $36.00. Facebook shares closed at $27.07 yesterday.

Stifel Nicolaus upgraded Teradata (NYSE: TDC) from “hold” to “buy.” The target price for Teradata is set to $63. Teradata's shares closed at $51.89 yesterday.

JP Morgan upgraded Mobile TeleSystems (NYSE: MBT) from “neutral” to “overweight.” Mobile TeleSystems' shares closed at $19.84 yesterday.

Latest Ratings for CELG

DateFirmActionFromTo
Feb 2015JefferiesMaintainsBuy
Jan 2015CitigroupMaintainsBuy
Jan 2015Deutsche BankMaintainsBuy

View More Analyst Ratings for CELG
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (CELG + FB)

Around the Web, We're Loving...